Clinical pathological gene research for the pathophysiology and diagnostic accuracy of pancreatic tumors

Clinical pathological gene research for the pathophysiology and diagnostic accuracy of pancreatic tumors - Genetic research of pancreatic tumors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044562

Enrollment

350

Registered

2021-06-16

Start date

2018-11-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pancreatic cancer patients. Patients who underwent surgery or detailed examination for pancreatic tumor. Control patients.

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

Measure	Time frame
Positive rate of genetic markers that relate prognosis.	—

Secondary

Measure	Time frame
To identify clinical factors that relate prognosis. Overall gene mutation rate and molecular marker expression rate. Expression rate of gene mutations and molecular markers associated with each clinical factors.	—

Countries

Japan

Contacts

Public ContactShinichi Takano

University of Yamanashi Division of gastroenterology and hepatology

stakano@yamanashi.ac.jp055-273-9584

Outcome results